查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1193067

顱內動脈瘤市場：按類型（手術夾閉、血管內彈簧圈、分流器等）按最終用戶（醫院、診所、其他）分類：2021-2031 年全球機會分析和行業預測

Intracranial Aneurysm Market By Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, Others), By End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 243 Pages | 商品交期: 2-3個工作天內

價格

2021 年全球顱內動脈瘤市場價值 130189 萬美元，2031 年達到 270979 萬美元，2022 年至 2031 年的複合年增長率預計為 7.6%。

腦動脈或顱內動脈瘤是由於血管壁內肌層（內膜）弱化引起的大腦動脈異常局部擴張，這種擴張會導致腦動脈瘤。 血管會變得擴張、“水泡”狀、變薄，並在沒有警告的情況下破裂。 結果是出血到大腦周圍的空間，稱為蛛網膜下腔出血 (SAH)。 這種出血會導致中風、昏迷和死亡。

動脈瘤通常位於大腦底部，就在顱骨內部，在稱為蛛網膜下腔的區域中。 事實上，90% 的蛛網膜下腔出血 (SAH) 是由腦動脈瘤破裂引起的。 然而，有多種因素被認為會導致腦動脈瘤的形成，包括高血壓、吸煙、先天易感性、血管損傷/外傷以及某些類型的血液感染引起的並發症。

推動市場增長的主要因素包括腦血管病患者人數的增加和患有高血壓的老年人口的快速增加。 例如，腦動脈瘤基金會發布的一份報告估計，美國有 650 萬人患有未破裂的腦動脈瘤，即每 50 人中就有 1 人。 此外，每年的破裂率約為每 10 萬人中有 8 至 10 人，美國每年約有 3 萬人患有腦動脈瘤破裂。 此外，據報導，女性比男性更容易患腦動脈瘤（比例為3:2），尤其是55歲及以上的人患腦動脈瘤破裂的風險比男性高（約為男性的1.5倍）。 全世界每年有近 50 萬人死於腦動脈瘤，其中一半年齡在 50 歲以下。 腦血管病是由於高血壓、吸煙、不健康的生活方式等導致血管受損，導致腦動脈瘤。 此外，對微創手術的需求不斷增加將推動市場增長，因為小切口可減少術後疼痛並促進快速恢復，從而導致這些手術在開顱手術中得到廣泛採用。我會給你提振。 許多主要參與者不斷投資於研發活動，以推出創新的微創血管內捲繞器械，這有望推動市場增長。

然而，治療動脈瘤引起的蛛網膜下腔出血的高成本和手術過程中的高健康風險阻礙了市場增長。 另一方面，發展中國家和低收入國家的新興醫療保健市場缺乏基本醫療保健，大流行病和高血壓相關疾病的風險增加，預計將在預測期內為市場增長提供有利可圖的機會。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章顱內動脈瘤市場：按類型

  • 概覽
    • 市場規模和預測
  • 手術剪報
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 血管內彈簧圈
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 分流器
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 5 章顱內動脈瘤市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家/地區分類
  • 醫務室
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 6 章顱內動脈瘤市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按類型
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按類型
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲
  • 亞太地區
    • 主要趨勢和機會
    • 亞太市場規模和預測：按類型
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按類型
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第七章商業條件

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第八章公司簡介

  • B. Braun
  • Delta Surgical
  • Evonos GmbH & Co. KG
  • Integra Life-science Holding Corporation
  • Medtronic PLC
  • Microport Scientific Corporation
  • Mizuho Medical Incorporation
  • Spiegelberg
  • Stryker Corporation
  • Terumo Global（Microvention）
Product Code: A10205

The global intracranial aneurysm market was valued at $1,301.89 million in 2021, and is projected to reach $2,709.79 million by 2031, registering a CAGR of 7.6% from 2022 to 2031.A cerebral or intracranial aneurysm is an abnormal focal dilation of an artery in the brain that results from weakening of the inner muscular layer (the intima) of a blood vessel wall. The vessel develops a "blister-like" dilation that can become thin and rupture without warning. This results in bleeding into the space around the brain, which is called a subarachnoid hemorrhage (SAH). This kind of hemorrhage can lead to a stroke, coma, and/or death.

Aneurysms are usually found at the base of brain, just inside the skull, in an area called subarachnoid space. In fact, ruptured cerebral aneurysms are responsible for 90% of subarachnoid hemorrhage (SAH). However, a number of factors are believed to contribute in formation of cerebral aneurysms, including hypertension, smoking, congenital predisposition, injury, or trauma to blood vessels and complications from some types of blood infections.

Key factors that drive growth of the market include rise in number of patients suffering from cerebrovascular disease and surge in geriatric population suffering from hypertension. For instance, according to a report published by the Brain Aneurysm Foundation, it has been estimated that 6.5 million people in the U.S. have an unruptured brain aneurysm i.e., 1 in 50 people. The annual rate of rupture is approximately 8-10 per 100,000 people and around 30,000 people in the U.S. suffer a brain aneurysm rupture each year. Moreover, it has been reported that women are more likely than men to have a brain aneurysm (3:2 ratio), particularly those over the age of 55 have a higher risk of brain aneurysm rupture than men (about 1.5 times the risk). There are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half the victims are younger than 50. The reason behind rise in prevalence of cerebrovascular disease are hypertension, cigarette smoking, and unhealthy lifestyle which leads to injury or trauma to blood vessels causing brain aneurysm. Furthermore, rise in the demand for minimally invasive surgeries, as smaller incisions decrease postoperative pain and facilitate speedy recovery leading to high adoption of these procedures for craniotomy surgery boost the market growth. Numerous key players are continuously investing in R&D activities for the launch of innovative minimally invasive endovascular coiling instruments are anticipated to fuel the market growth.

However, high management cost of aneurysm subarachnoid hemorrhage and high health risk during surgeries hamper the market growth. Conversely, emerging healthcare markets in developing countries and low-income countries lacking access to basic healthcare and increase in risk of pandemic and hypertension related disorders is expected to provide the lucrative opportunity for the growth of market during the forecast period. 

The intracranial aneurysm market is segmented on the basis of type, end user, and region. By type the market is segmented into surgical clipping, endovascular coiling, flow diverters, and others. By end user, it segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the intracranial aneurysm market share in 2021, and is anticipated to remain dominant during the forecast period, owing to the presence of well-established healthcare facilities, a growing geriatric population, and a high incidence of hypertension and stroke. Moreover, increase in prevalence of intracranial aneurysms and rise in demand for minimally invasive procedures contribute toward the market growth in the region. Furthermore, increase in number of initiatives undertaken by various organizations to spread awareness and reduce number of deaths due to cerebral aneurysms through innovative research is expected to fuel the market growth.

Asia-Pacific is expected to register fastest CAGR during the forecast period. This is attributed to presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, rapidly growing geriatric population, lifestyle stress, rise in incidences of hypertension, large population, improvement in quality of diagnosis, and increase in patient affordability are expected to drive the market in Asia-Pacific. This helps several market players to invest in Asia-Pacific countries, which further contributes toward growth of the market.

Key players that operate in the Intracranial aneurysm market are B. Braun, Delta Surgical, Evonos GmbH & Co. KG, Integra Lifescience Holding Corporation, Medtronic PLC, Microport Scientific Corporation, Mizuho Medical Incorporation, Spiegelberg, Stryker Corporation, and Terumo Global (Microvention).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intracranial aneurysm market analysis from 2021 to 2031 to identify the prevailing intracranial aneurysm market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the intracranial aneurysm market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global intracranial aneurysm market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Surgical Clipping
  • Endovascular Coiling
  • Flow Diverters
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Rest of Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • B. Braun
    • Delta Surgical
    • Evonos GmbH & Co. KG
    • Integra Life-science Holding Corporation
    • Medtronic PLC
    • Microport Scientific Corporation
    • Mizuho Medical Incorporation
    • Spiegelberg
    • Stryker Corporation
    • Terumo Global (Microvention)

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: INTRACRANIAL ANEURYSM MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Surgical Clipping
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Endovascular Coiling
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Flow Diverters
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country

CHAPTER 5: INTRACRANIAL ANEURYSM MARKET, BY END USER

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Hospitals
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Clinics
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Others
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: INTRACRANIAL ANEURYSM MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Type
    • 6.2.3 North America Market size and forecast, by End User
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Market size and forecast, by Type
      • 6.2.4.1.2 Market size and forecast, by End User
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Market size and forecast, by Type
      • 6.2.4.2.2 Market size and forecast, by End User
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Market size and forecast, by Type
      • 6.2.4.3.2 Market size and forecast, by End User
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Type
    • 6.3.3 Europe Market size and forecast, by End User
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Market size and forecast, by Type
      • 6.3.4.1.2 Market size and forecast, by End User
      • 6.3.4.2 France
      • 6.3.4.2.1 Market size and forecast, by Type
      • 6.3.4.2.2 Market size and forecast, by End User
      • 6.3.4.3 UK
      • 6.3.4.3.1 Market size and forecast, by Type
      • 6.3.4.3.2 Market size and forecast, by End User
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Market size and forecast, by Type
      • 6.3.4.4.2 Market size and forecast, by End User
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Market size and forecast, by Type
      • 6.3.4.5.2 Market size and forecast, by End User
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Market size and forecast, by Type
      • 6.3.4.6.2 Market size and forecast, by End User
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Type
    • 6.4.3 Asia-Pacific Market size and forecast, by End User
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 Japan
      • 6.4.4.1.1 Market size and forecast, by Type
      • 6.4.4.1.2 Market size and forecast, by End User
      • 6.4.4.2 China
      • 6.4.4.2.1 Market size and forecast, by Type
      • 6.4.4.2.2 Market size and forecast, by End User
      • 6.4.4.3 Australia
      • 6.4.4.3.1 Market size and forecast, by Type
      • 6.4.4.3.2 Market size and forecast, by End User
      • 6.4.4.4 India
      • 6.4.4.4.1 Market size and forecast, by Type
      • 6.4.4.4.2 Market size and forecast, by End User
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Market size and forecast, by Type
      • 6.4.4.5.2 Market size and forecast, by End User
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Market size and forecast, by Type
      • 6.4.4.6.2 Market size and forecast, by End User
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Type
    • 6.5.3 LAMEA Market size and forecast, by End User
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Market size and forecast, by Type
      • 6.5.4.1.2 Market size and forecast, by End User
      • 6.5.4.2 Saudi Arabia
      • 6.5.4.2.1 Market size and forecast, by Type
      • 6.5.4.2.2 Market size and forecast, by End User
      • 6.5.4.3 South Africa
      • 6.5.4.3.1 Market size and forecast, by Type
      • 6.5.4.3.2 Market size and forecast, by End User
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Market size and forecast, by Type
      • 6.5.4.4.2 Market size and forecast, by End User

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 B. Braun
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Delta Surgical
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Evonos GmbH & Co. KG
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Integra Life-science Holding Corporation
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Medtronic PLC
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Microport Scientific Corporation
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Mizuho Medical Incorporation
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Spiegelberg
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Stryker Corporation
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Terumo Global (Microvention)
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. INTRACRANIAL ANEURYSM MARKET, FOR SURGICAL CLIPPING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. INTRACRANIAL ANEURYSM MARKET FOR SURGICAL CLIPPING, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. INTRACRANIAL ANEURYSM MARKET, FOR ENDOVASCULAR COILING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. INTRACRANIAL ANEURYSM MARKET FOR ENDOVASCULAR COILING, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. INTRACRANIAL ANEURYSM MARKET, FOR FLOW DIVERTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. INTRACRANIAL ANEURYSM MARKET FOR FLOW DIVERTERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. INTRACRANIAL ANEURYSM MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. INTRACRANIAL ANEURYSM MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 11. INTRACRANIAL ANEURYSM MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. INTRACRANIAL ANEURYSM MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. INTRACRANIAL ANEURYSM MARKET, FOR CLINICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. INTRACRANIAL ANEURYSM MARKET FOR CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. INTRACRANIAL ANEURYSM MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. INTRACRANIAL ANEURYSM MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. INTRACRANIAL ANEURYSM MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 19. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 20. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. U.S. INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 22. U.S. INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 23. CANADA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 24. CANADA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 25. MEXICO INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 26. MEXICO INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 27. EUROPE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. EUROPE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 29. EUROPE INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. GERMANY INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 31. GERMANY INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 32. FRANCE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 33. FRANCE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 34. UK INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 35. UK INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 36. ITALY INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 37. ITALY INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. SPAIN INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 39. SPAIN INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 40. REST OF EUROPE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 41. REST OF EUROPE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 43. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 45. JAPAN INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 46. JAPAN INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 47. CHINA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 48. CHINA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. AUSTRALIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 50. AUSTRALIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 51. INDIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 52. INDIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 53. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 54. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 56. REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 57. LAMEA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 58. LAMEA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 59. LAMEA INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 60. BRAZIL INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. BRAZIL INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 62. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 63. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 66. REST OF LAMEA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 67. REST OF LAMEA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68.B. BRAUN: COMPANY SNAPSHOT
  • TABLE 69.B. BRAUN: OPERATING SEGMENTS
  • TABLE 70.B. BRAUN: PRODUCT PORTFOLIO
  • TABLE 71.B. BRAUN: NET SALES,
  • TABLE 72.B. BRAUN: KEY STRATERGIES
  • TABLE 73.DELTA SURGICAL: COMPANY SNAPSHOT
  • TABLE 74.DELTA SURGICAL: OPERATING SEGMENTS
  • TABLE 75.DELTA SURGICAL: PRODUCT PORTFOLIO
  • TABLE 76.DELTA SURGICAL: NET SALES,
  • TABLE 77.DELTA SURGICAL: KEY STRATERGIES
  • TABLE 78.EVONOS GMBH & CO. KG: COMPANY SNAPSHOT
  • TABLE 79.EVONOS GMBH & CO. KG: OPERATING SEGMENTS
  • TABLE 80.EVONOS GMBH & CO. KG: PRODUCT PORTFOLIO
  • TABLE 81.EVONOS GMBH & CO. KG: NET SALES,
  • TABLE 82.EVONOS GMBH & CO. KG: KEY STRATERGIES
  • TABLE 83.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: COMPANY SNAPSHOT
  • TABLE 84.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: OPERATING SEGMENTS
  • TABLE 85.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: PRODUCT PORTFOLIO
  • TABLE 86.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: NET SALES,
  • TABLE 87.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: KEY STRATERGIES
  • TABLE 88.MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 89.MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 90.MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 91.MEDTRONIC PLC: NET SALES,
  • TABLE 92.MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 93.MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 94.MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 95.MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 96.MICROPORT SCIENTIFIC CORPORATION: NET SALES,
  • TABLE 97.MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 98.MIZUHO MEDICAL INCORPORATION: COMPANY SNAPSHOT
  • TABLE 99.MIZUHO MEDICAL INCORPORATION: OPERATING SEGMENTS
  • TABLE 100.MIZUHO MEDICAL INCORPORATION: PRODUCT PORTFOLIO
  • TABLE 101.MIZUHO MEDICAL INCORPORATION: NET SALES,
  • TABLE 102.MIZUHO MEDICAL INCORPORATION: KEY STRATERGIES
  • TABLE 103.SPIEGELBERG: COMPANY SNAPSHOT
  • TABLE 104.SPIEGELBERG: OPERATING SEGMENTS
  • TABLE 105.SPIEGELBERG: PRODUCT PORTFOLIO
  • TABLE 106.SPIEGELBERG: NET SALES,
  • TABLE 107.SPIEGELBERG: KEY STRATERGIES
  • TABLE 108.STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 109.STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 110.STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 111.STRYKER CORPORATION: NET SALES,
  • TABLE 112.STRYKER CORPORATION: KEY STRATERGIES
  • TABLE 113.TERUMO GLOBAL (MICROVENTION): COMPANY SNAPSHOT
  • TABLE 114.TERUMO GLOBAL (MICROVENTION): OPERATING SEGMENTS
  • TABLE 115.TERUMO GLOBAL (MICROVENTION): PRODUCT PORTFOLIO
  • TABLE 116.TERUMO GLOBAL (MICROVENTION): NET SALES,
  • TABLE 117.TERUMO GLOBAL (MICROVENTION): KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.INTRACRANIAL ANEURYSM MARKET SEGMENTATION
  • FIGURE 2.INTRACRANIAL ANEURYSM MARKET,2021-2031
  • FIGURE 3.INTRACRANIAL ANEURYSM MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.INTRACRANIAL ANEURYSM MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.INTRACRANIAL ANEURYSM MARKET,BY TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SURGICAL CLIPPING INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ENDOVASCULAR COILING INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FLOW DIVERTERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 17.INTRACRANIAL ANEURYSM MARKET,BY END USER,2021(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOSPITALS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CLINICS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
  • FIGURE 21.INTRACRANIAL ANEURYSM MARKET BY REGION,2021
  • FIGURE 22.U.S. INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 23.CANADA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 24.MEXICO INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 25.GERMANY INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 26.FRANCE INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 27.UK INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 28.ITALY INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 29.SPAIN INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 30.REST OF EUROPE INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 31.JAPAN INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 32.CHINA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 33.AUSTRALIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 34.INDIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 35.SOUTH KOREA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 36.REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 37.BRAZIL INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 38.SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 39.SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF LAMEA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45.COMPETITIVE DASHBOARD
  • FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 47.B. BRAUN.: NET SALES ,($MILLION)
  • FIGURE 48.DELTA SURGICAL.: NET SALES ,($MILLION)
  • FIGURE 49.EVONOS GMBH & CO. KG.: NET SALES ,($MILLION)
  • FIGURE 50.INTEGRA LIFE-SCIENCE HOLDING CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 51.MEDTRONIC PLC.: NET SALES ,($MILLION)
  • FIGURE 52.MICROPORT SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 53.MIZUHO MEDICAL INCORPORATION.: NET SALES ,($MILLION)
  • FIGURE 54.SPIEGELBERG.: NET SALES ,($MILLION)
  • FIGURE 55.STRYKER CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 56.TERUMO GLOBAL (MICROVENTION).: NET SALES ,($MILLION)